Land: New Zealand
Sprog: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Clonidine 7.5mg
CARSL Consulting
Clonidine 7.5 mg
7.5 mg
Transdermal patch
Active: Clonidine 7.5mg Excipient: Calcium stearate
Sachet, 4 patches
Prescription
Prescription
Boehringer Ingelheim Pharma GmbH & Co KG
CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
Package - Contents - Shelf Life: Sachet, - 4 patches - 36 months from date of manufacture stored at or below 25°C
1984-12-12
NEW ZEALAND CONSUMER MEDICINE INFORMATION CATAPRES TTS _CLONIDINE HYDROCHLORIDE _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about CATAPRES TTS. It does not contain all available information. It does not take the place of talking to your doctor or pharmacist. Keep this information with your CATAPRES TTS. You may need to read it again later. _TO FIND OUT MORE ABOUT CATAPRES _ Ask your doctor or pharmacist if you have any questions about your medicine or if you have any trouble before, during or after using CATAPRES. WHAT CATAPRES IS USED FOR CATAPRES lowers high blood pressure, also called hypertension. Everyone has blood pressure. This pressure helps your blood move around your body. Your blood pressure may be different at different times of the day. You have hypertension when your blood pressure stays higher than normal, even when you are calm or relaxed. There are usually no signs of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. You may feel fine and have no symptoms, but if high blood pressure is not treated, it can lead to serious health problems (such as heart disease). CATAPRES works by relaxing and widening blood vessels and so helps to lower your blood pressure. Your doctor may prescribe CATAPRES for other reasons. Ask your doctor if you have any questions about why CATAPRES has been prescribed for you. BEFORE YOU USE CATAPRES _WHEN YOU MUST NOT USE CATAPRES _ Only use CATAPRES if it has been prescribed for you by a doctor. Never give it to someone else even if their symptoms seem to be the same as yours. Do not use CATAPRES if you have certain heart problems, such as irregular/slow heart beat. Do not use CATAPRES after the EXPIRY DATE on the carton has passed. Do not use CATAPRES if the packaging is torn or shows signs of tampering. _BEFORE YOU START TO USE CATAPRES _ Before using CATAPRES, you must tell your doctor if you have, or have had, any of the following conditions: • heart failure or any h Læs hele dokumentet
NEW ZEALAND DATASHEET 1 PRODUCT NAME CATAPRES ® - TTS ® 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Clonidine 3 PHARMACEUTICAL FORM TRANSDERMAL THERAPEUTIC SYSTEM NO. 1 (PATCH): 2.5mg/3.5cm², printed with Company symbol and BI 31. TRANSDERMAL THERAPEUTIC SYSTEM NO. 2 (PATCH): 5mg/7.0cm², printed with Company symbol and BI 32. TRANSDERMAL THERAPEUTIC SYSTEM NO. 3 (PATCH): 7.5mg/10.5cm², printed with Company symbol and BI 33. The rate of release of clonidine and content of clonidine in each system is given in the table below: Programmed Delivery _In vivo_/day Over 1 week Clonidine content (mg) Size (cm²) CATAPRES-TTS-1 0.1mg 2.5 3.5 CATAPRES-TTS-2 0.2mg 5.0 7.0 CATAPRES-TTS-3 0.3mg 7.5 10.5 4 CLINICAL PARTICULARS 4.1 Therapeutic indications CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect. 4.2 Dose and method of administration CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned, hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If the system loosens during 7-day wearing, the adhesive cover should be applied directly over the system to ensure good adhesion. There have been rare reports of the need for patch changes prior to 7 days to maintain blood pressure control. If after one to two weeks the desired reduction in blood pressure is not achieved, increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 1-2 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3. Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3, it is recommended that a diuretic and/or other antihypertensive Læs hele dokumentet